- Home
- ARCT vs RXST Comparison
ARCT vs RXST Comparison
Compare ARCT & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- RXST
- Stock Information
- Founded
- ARCT 2013
- RXST 1997
- Country
- ARCT United States
- RXST United States
- Employees
- ARCT N/A
- RXST N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ARCT Health Care
- RXST Health Care
- Exchange
- ARCT Nasdaq
- RXST Nasdaq
- Market Cap
- ARCT 320.8M
- RXST 365.8M
- IPO Year
- ARCT N/A
- RXST 2021
- Fundamental
- Price
- ARCT $17.32
- RXST $9.31
- Analyst Decision
- ARCT Strong Buy
- RXST Hold
- Analyst Count
- ARCT 10
- RXST 11
- Target Price
- ARCT $50.88
- RXST $11.80
- AVG Volume (30 Days)
- ARCT 536.4K
- RXST 1.1M
- Earning Date
- ARCT 11-06-2025
- RXST 11-06-2025
- Dividend Yield
- ARCT N/A
- RXST N/A
- EPS Growth
- ARCT N/A
- RXST N/A
- EPS
- ARCT N/A
- RXST N/A
- Revenue
- ARCT $122,122,000.00
- RXST $147,059,000.00
- Revenue This Year
- ARCT N/A
- RXST N/A
- Revenue Next Year
- ARCT $31.09
- RXST $6.71
- P/E Ratio
- ARCT N/A
- RXST N/A
- Revenue Growth
- ARCT N/A
- RXST 27.68
- 52 Week Low
- ARCT $8.04
- RXST $6.32
- 52 Week High
- ARCT $25.88
- RXST $57.53
- Technical
- Relative Strength Index (RSI)
- ARCT 54.49
- RXST 54.22
- Support Level
- ARCT $17.38
- RXST $8.29
- Resistance Level
- ARCT $18.69
- RXST $10.25
- Average True Range (ATR)
- ARCT 1.00
- RXST 0.53
- MACD
- ARCT -0.11
- RXST 0.12
- Stochastic Oscillator
- ARCT 44.23
- RXST 52.04
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.